Roivant Sciences (NASDAQ:ROIV) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Roivant Sciences (NASDAQ:ROIV) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.24, beating the consensus estimate of $-0.34 by $0.10 per share. Revenue came in at $2.0M, missing the estimate of $6.1M.
Roivant Sciences's stock moved following the earnings release. The stock currently trades at $26.38 with a market capitalization of $14.8B.
Current market data
NASDAQ · ROIV
$34.71
Down: -$2.87 · -7.64%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
earnings ·
sec_filing ·
institutional ·
sec_filing ·
